A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of Afinitor
by on Monday, July 11th, 2011 | No Comments
Condition: Metastatic Renal Cell Carcinoma (mRCC)
Intervention: Other: everolimis
Sponsor: Novartis Pharmaceuticals
Recruiting – verified July 2011
Read this article: A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of Afinitor